Impact of mecA Gene Testing and Intervention by Infectious Disease Clinical Pharmacists on Time to Optimal Antimicrobial Therapy for Staphylococcus aureus Bacteremia at a University Hospital
- 1 July 2008
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (7), 2381-2383
- https://doi.org/10.1128/jcm.00801-08
Abstract
In patients with Staphylococcus aureus bacteremia, intervention by infectious disease clinical pharmacists on the basis of the results of tests for mecA resulted in a 25.4-h reduction in the time to optimal antimicrobial therapy, from 64.7 ± 36.8 to 39.3 ± 15.5 h ( P = 0.002), which may result in decreased mortality.Keywords
This publication has 4 references indexed in Scilit:
- Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2007
- Identification of Methicillin‐ResistantStaphylococcus aureusCarriage in Less than 1 Hour during a Hospital Surveillance ProgramClinical Infectious Diseases, 2005
- A Prospective Multicenter Study of Staphylococcus aureus BacteremiaMedicine, 2003
- Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2003